Objective Dendritic cells (DCs) have long been recognized as potential therapeutic targets of rheumatoid arthritis (RA). Increasing evidence has showed that DCs are capable of suppressing autoimmunity by expanding FoxP3 + regulatory T cells (T reg), which in turn exert immunosuppression by increasing TGFÎČ-1. In the SKG mice, activated DC prime autoreactive T cells causing autoantibody production and an inflammatory arthritic response. Recently, we reported that CC-chemokine receptor-2 deficient ( Ccr2 â/â) mice had impaired DCs migration and reduced CD8α + DCs in the C57Bl/6J mice strain and that these mice were more susceptible to collagen antibody-induced arthritis (CAIA), compared to wild type mice. To examine the mechanism by which DCs contribute to the increased susceptibility of arthritis in Ccr2 â/â mice, we tested the hypothesis that CD8α + DCs are protective (tolerogenic) against autoimmune arthritis by examining the role of CD8α + DCs in Ccr2 â/â and SKG mice. Methods To examine the mechanism by which DCs defects lead to the development of arthritis, we used two murine models of experimental arthritis: collagen-induced arthritis (CIA) in DBA1/J mice and zymosan-induced arthritis in SKG mice. DBA1/J mice received recombinant fms-like tyrosine kinase 3 ligand (Flt3L) injections to expand endogenous DCs populations or adoptive transfers of CD8α + DCs. Results Flt3L-mediated expansion of endogenous CD8α + DCs resulted in heightened susceptibility of CIA. In contrast, supplementation with exogenous CD8α + DCs ameliorated arthritis in Ccr2 â/â mice and enhanced TGFÎČ1 production by T cells. Furthermore, SKG mice with genetic inactivation of CCR2 did not affect the numbers of DCs nor improve the arthritis phenotype. Conclusion CD8α + DCs were tolerogenic to the development of arthritis. CD8α + DCs deficiency heightened the sensitivity to arthritis in Ccr2 â/â mice. Ccr2 deficiency did not alter the arthritic phenotype in SKG mice suggesting the arthritis in Ccr2 â/â mice was T cell-independent.